Important fatty acids from fish oil - EFAs
Historically,
Americans obtained 40% of their fat from omega-3
oils. Today only 5% of our fat consists of these
oils. Populations who still eat quantities of
deep-sea fish do not share many of the typical
"modern" degenerative diseases such as heart
disease.
Benefits of omega-3 oils include lower LDL
cholesterol and triglyceride levels in the blood,
improved circulation with decreased platelet
stickiness, reduced blood pressure and improved
immune system function. Fish oils may affect the
nervous system and improve symptoms of mental
illness and the effectiveness of niacin.
Fish oil quality is an important issue. Avoid
"fish oils" from "mixed marine" sources. Many are
bottom-feeders with little DHA or EPA and may be
contaminated with pollutants. This Omega-3
supplement is of extremely high quality.
This supplement's purity goes far beyond cold
filtration - it is processed with molecular
filtration - only a few supplements on the market
today have this level of purity. Most
supplement companies cannot every measure down to
the contamination levels to which this product is
specified. Guaranteed Pure to ppb
levels (parts per billion). This Omega-3
product is so pure that you can literally chew the
capsules like candy. There is no fish taste-
(I do it every day and I cannot stand bad
tastes)
Research: Double-blind studies shown
omega-3 from fish oil is benefical for the
following conditions: High triglycerides, Crohn’s
disease, High blood pressure, and Rheumatoid
arthritis.1 2 3 The anti-inflammatory
effects of EPA and DHA also account for the
findings that show fish oil is useful for kidney
diseases4 and may help protect against
chronic obstructive pulmonary disease.5
Depression is yet another use.6
(1) Von Schacky C, Angerer P, et al. Ann Intern
Med 1999;130:554-62.
(2) Mate J, Castanos R, et al. Gastroenterology
1991;100:A228
(3) Kremer JM, Lawrence DA, Petrillow GF, et al.
Arthritis Rheum 1995;38:1107
(4) Donadio JV Jr, Bergstrahl EJ, Offord KP, et
al. N Engl J Med 1994;331:1194
(5) Shahar E, Folsom AR, Melnick SL, et al. N
Engl J Med 1994;331:228-33.
(6) Maes M, Smith R, Christophe A, et al.
Affect Disord 1996;38:35–46.